Renal & Urinary

Respiratory acidosis and alkalosis: compensation analysis

Clinical Overview and When to Suspect Respiratory Acid-Base Disorders

— COPD exacerbation, asthma fatigue, OSA/OHS, opioid/benzodiazepine overdose, myasthenic crisis, Guillain-Barré, kyphoscoliosis, morbid obesity

— Step 1: identify primary disturbance (pH direction + PaCO₂ direction)

— Step 2: acute vs chronic (HCO₃⁻ magnitude of change)

— Step 3: calculate expected compensation

— Step 4: if observed ≠ expected → mixed disorder

— Step 5: in metabolic acidosis context, also check anion gap and delta-delta

Respiratory acidosis = primary ↑PaCO₂ (>45 mmHg) from alveolar hypoventilation; respiratory alkalosis = primary ↓PaCO₂ (<35 mmHg) from hyperventilation

Suspect respiratory acidosis in any patient with depressed mental status, neuromuscular weakness, severe airway/parenchymal disease, or chest wall pathology

Suspect respiratory alkalosis in anxiety/pain, sepsis (early), PE, hypoxemia of any cause, pregnancy, salicylate toxicity, hepatic failure, CNS lesions, high altitude, mechanical overventilation

The clinical question on Step 3 is rarely "is the ABG abnormal?" — it is "is compensation appropriate, and if not, what second disorder is hiding?"

Workflow when ABG returns:

Board pearl: The body never overcompensates. If pH crosses normal in the opposite direction of the primary process, a second primary disorder exists.

Key distinction: Compensation for a respiratory disorder is metabolic (renal HCO₃⁻ handling, slow); compensation for a metabolic disorder is respiratory (ventilation, fast — minutes). This asymmetry is why acute respiratory disorders show minimal HCO₃⁻ change while chronic ones show robust renal adaptation over 3–5 days.

Step 3 management: Do not chase the number — treat the underlying cause (naloxone, BiPAP, bronchodilators, anxiolysis, treat sepsis). Bicarbonate is almost never the answer in pure respiratory acidosis.

Presentation Patterns and Key History

— Triggers: opioid OD, benzodiazepine OD, post-anesthesia, acute neuromuscular failure, severe asthma, pneumothorax, foreign body

— COPD, OHS, severe kyphoscoliosis, late ALS, chronic opioid use

— Patients may have PaCO₂ 55–70 mmHg with near-normal pH and minimal symptoms

— Triggers: panic attack, PE, early sepsis, salicylate toxicity, pain, fever, altitude, ASA OD

— Medication list (opioids, sedatives, salicylates — both alkalosis and AGMA), drug ingestions, recent surgery/anesthesia

— Sleep symptoms (snoring, witnessed apnea, morning headaches → OSA/OHS)

— Progressive limb weakness, diplopia, dysphagia (neuromuscular cause)

— Travel/altitude, pregnancy status, fever, leg swelling/immobility (PE)

Acute respiratory acidosis presents with rapid CO₂ rise and CNS depression — somnolence, confusion, asterixis, headache, papilledema (cerebral vasodilation), and ultimately CO₂ narcosis/coma when PaCO₂ >70–80 mmHg acutely

Chronic respiratory acidosis is often well-tolerated due to renal compensation

Acute respiratory alkalosis: paresthesias (perioral, fingertips), carpopedal spasm (↓ionized Ca²⁺ from alkalemia), lightheadedness, chest tightness, anxiety

Chronic respiratory alkalosis: pregnancy (progesterone-driven), chronic liver disease, chronic high altitude, interstitial lung disease — typically asymptomatic

History red flags to elicit:

Board pearl: A tachypneic patient with paresthesias and a normal CXR — think PE before panic. Anxiety is a diagnosis of exclusion in adults with new hyperventilation.

Key distinction: Salicylate toxicity classically gives a mixed primary respiratory alkalosis + AGMA (direct medullary stimulation + uncoupled oxidative phosphorylation). pH may be near-normal; tinnitus and hyperpnea are clues.

Step 3 management: In suspected opioid-induced hypercapnia, give naloxone and monitor for re-sedation — duration of opioid often exceeds naloxone's 30–60 min half-life; admit for observation.

Physical Exam Findings and Hemodynamic Assessment

— Somnolent, unable to protect airway, RR <8 or >35 → escalate immediately

— Tripoding, accessory muscle use, paradoxical abdominal motion = impending failure

— Cyanosis (if concurrent hypoxemia), plethora, conjunctival injection (CO₂ vasodilation)

— Asterixis — coarse flapping tremor; classic for CO₂ narcosis, also uremia/hepatic

— Bounding pulses, warm extremities, headache, papilledema from cerebral vasodilation

— Pursed-lip breathing, barrel chest, prolonged expiration (COPD)

— Bulbar weakness, ptosis, fatigable strength (myasthenia); ascending weakness + areflexia (GBS)

— Tachypnea, deep regular breaths (Kussmaul-like in salicylate toxicity)

— Chvostek and Trousseau signs from alkalemia-induced ↓ionized Ca²⁺

— Carpopedal spasm, perioral tingling

— Tremor, hyperreflexia

— Severe acidemia (pH <7.20) → ↓myocardial contractility, arrhythmogenesis, catecholamine resistance, pulmonary vasoconstriction

— Severe alkalemia (pH >7.55) → coronary vasoconstriction, ↓cerebral perfusion, ↓ionized Ca²⁺ → tetany, arrhythmias

— Check for JVD, S3, peripheral edema in OHS/cor pulmonale

General appearance and mental status drive triage decisions more than ABG numbers

Respiratory acidosis signs:

Respiratory alkalosis signs:

Hemodynamic assessment:

Pulse oximetry pitfall: SpO₂ does not detect hypercapnia. A patient on supplemental O₂ may have SpO₂ 98% with PaCO₂ 90 mmHg — always check ABG/VBG if mental status changes.

Board pearl: In chronic CO₂ retainers, giving uncontrolled high-flow O₂ can worsen hypercapnia (V/Q mismatch + Haldane effect, not just loss of hypoxic drive). Target SpO₂ 88–92% in COPD.

CCS pearl: Order continuous pulse oximetry, cardiac monitor, and serial neuro checks for any patient with acute hypercapnia — do not wait for the next ABG to act on a deteriorating exam.

Diagnostic Workup — Initial Labs and ABG Interpretation

— pH <7.35 = acidemia; >7.45 = alkalemia

— PaCO₂ change in same direction as pH → metabolic process; opposite direction → respiratory process

— Respiratory acidosis: ↓pH, ↑PaCO₂; Respiratory alkalosis: ↑pH, ↓PaCO₂

— Anion gap = Na − (Cl + HCO₃); normal 8–12. Critical when ruling out concurrent metabolic disorders

— Acute: HCO₃⁻ ↑ by 1 (cellular buffering)

— Chronic: HCO₃⁻ ↑ by 3.5–4 (renal NH₄⁺ excretion, takes 3–5 days)

— Acute: HCO₃⁻ ↓ by 2

— Chronic: HCO₃⁻ ↓ by 4–5

Arterial blood gas is the gold standard; venous blood gas correlates well for pH and HCO₃⁻ (VBG PaCO₂ runs ~4–6 mmHg higher than ABG)

Normal values: pH 7.35–7.45, PaCO₂ 35–45 mmHg, HCO₃⁻ 22–26 mEq/L

Systematic ABG approach:

Always pair with basic metabolic panel for HCO₃⁻ (should match ABG ±2), anion gap, electrolytes, glucose, BUN/Cr

Acute vs chronic respiratory acidosis (HCO₃⁻ rise per 10 mmHg ↑PaCO₂):

Acute vs chronic respiratory alkalosis (HCO₃⁻ fall per 10 mmHg ↓PaCO₂):

pH change rule of thumb: Acute ↑PaCO₂ by 10 → pH ↓ by 0.08; chronic ↑PaCO₂ by 10 → pH ↓ by 0.03

Adjunct labs based on context: CBC, lactate, salicylate level, ethanol/tox screen, TSH, BNP, troponin, CK, D-dimer, β-hCG

CXR for all: look for pneumothorax, infiltrate, effusion, hyperinflation, cardiomegaly

ECG: arrhythmia, right heart strain (S1Q3T3 → PE), atrial enlargement (cor pulmonale)

Board pearl: If the BMP HCO₃⁻ differs from the ABG-calculated HCO₃⁻ by >2, repeat the ABG — lab error is likely.

Step 3 management: In any obtunded patient, get fingerstick glucose, ABG/VBG, BMP, tox screen, and head CT before deciding the etiology of altered mental status — do not assume.

Diagnostic Workup — Advanced and Confirmatory Studies

— Obstructive (FEV₁/FVC <0.7) → COPD, asthma

— Restrictive → neuromuscular, chest wall, ILD

— MIP/MEP (maximal inspiratory/expiratory pressures) assess respiratory muscle strength — low MIP suggests neuromuscular cause

— Acetylcholine receptor antibodies, edrophonium test (largely historical), repetitive nerve stimulation → myasthenia

— LP with albuminocytologic dissociation, NCS → Guillain-Barré

— EMG, genetic testing for ALS, muscular dystrophies

— Normal A-a gradient + hypercapnia → extrapulmonary hypoventilation (opioids, neuromuscular, CNS)

— Elevated A-a gradient + hypercapnia → intrinsic lung disease (COPD, ARDS, pneumonia)

CT pulmonary angiogram for suspected PE (Wells score ± D-dimer guidance); V/Q scan if contrast contraindicated

Polysomnography for OSA/OHS — confirms AHI, nocturnal hypoventilation, oxygen desaturation index

Pulmonary function tests for chronic hypercapnia workup:

Salicylate level if tinnitus, mixed acid-base, or unexplained tachypnea; co-order acetaminophen level

TSH — hypothyroidism (myxedema) can cause hypoventilation; hyperthyroidism can cause hyperventilation

Neuromuscular workup:

Echocardiogram for cor pulmonale, RV dysfunction, pulmonary hypertension (TR jet velocity)

Sleep oximetry as a screen for OHS in obese patients with daytime hypercapnia and HCO₃⁻ >27 without other cause

A-a gradient = [150 − (PaCO₂/0.8)] − PaO₂ (room air, sea level); normal ~(age/4)+4

Bedside spirometry (FVC, NIF): FVC <20 mL/kg, NIF less negative than −30 cmH₂O → intubation likely needed in neuromuscular disease (the 20/30/40 rule)

Board pearl: A normal A-a gradient with hypercapnia points you outside the lungs — think drugs, brainstem, or muscles.

Key distinction: Acute hypercapnia with clear lungs on CXR + pinpoint pupils = opioid OD until proven otherwise; with bilateral infiltrates = ARDS or pneumonia.

Compensation Analysis — The Core Framework

• Five-step approach every time:
— 1. Acidemia or alkalemia? (pH)
— 2. Primary disorder? (PaCO₂ vs HCO₃⁻ direction relative to pH)
— 3. Is compensation appropriate? (apply formula)
— 4. If metabolic acidosis, calculate anion gap and delta-delta (ΔAG/ΔHCO₃ ratio)
— 5. Synthesize — single, double, or triple disorder?
• Compensation formulas (memorize cold):
Primary disorder	Expected compensation
Acute resp acidosis	↑HCO₃ = 1 per 10 ↑PaCO₂
Chronic resp acidosis	↑HCO₃ = 3.5–4 per 10 ↑PaCO₂
Acute resp alkalosis	↓HCO₃ = 2 per 10 ↓PaCO₂
Chronic resp alkalosis	↓HCO₃ = 4–5 per 10 ↓PaCO₂
Metabolic acidosis	Winters: expected PaCO₂ = 1.5(HCO₃) + 8 ± 2
Metabolic alkalosis	↑PaCO₂ = 0.7 per 1 ↑HCO₃ (up to ~55)
• Interpreting compensation:
— Observed matches expected → simple disorder
— Observed > expected response → additional disorder in the same direction as the compensation
— Observed < expected response → additional disorder opposite to the compensation
• Example 1: pH 7.30, PaCO₂ 60, HCO₃ 28 — acute respiratory acidosis (expected HCO₃ = 24+2 = 26; observed 28 is close enough → simple acute, possibly transitioning)
• Example 2: pH 7.36, PaCO₂ 70, HCO₃ 38 — chronic respiratory acidosis (expected HCO₃ = 24 + 4×3 = 36; observed 38 → near-perfect compensation)
• Example 3: pH 7.50, PaCO₂ 60, HCO₃ 45 — alkalemia despite hypercapnia → mixed metabolic alkalosis + respiratory acidosis (e.g., COPD on loop diuretic)
• Board pearl: Use 0.08 (acute) / 0.03 (chronic) pH change per 10 mmHg ΔPaCO₂ to cross-check formulas mentally.
• CCS pearl: Don't just record the ABG — document your compensation calculation in the note; mixed disorders change management (e.g., adding a loop diuretic vs holding it).

Pharmacotherapy and Targeted Therapy — Respiratory Acidosis

— Naloxone 0.04–0.4 mg IV, titrate to respirations not consciousness; repeat q2–3 min

— Continuous infusion (⅔ of waking dose/hr) for long-acting opioids (methadone, sustained-release)

— Observation ≥4–6 h after last dose; longer for methadone (24 h)

— Short-acting bronchodilators: albuterol + ipratropium nebs q1–4 h

— Systemic corticosteroids (prednisone 40 mg PO × 5 days)

— Antibiotics if ≥2 of (↑dyspnea, ↑sputum volume, ↑sputum purulence) or mechanical ventilation: azithromycin, doxycycline, or amoxicillin-clavulanate × 5–7 d

— Controlled O₂ to SpO₂ 88–92% (Venturi mask preferred)

— NIPPV (BiPAP) for pH <7.35 with PaCO₂ >45 — reduces intubation, mortality, length of stay

Cardinal rule: Treat the cause, not the number. Bicarbonate is contraindicated in pure respiratory acidosis — it generates more CO₂ that the patient cannot exhale.

Opioid-induced hypoventilation:

Benzodiazepine overdose: Flumazenil rarely used — risk of seizures, especially in chronic users or co-ingestion with TCAs. Supportive ventilation preferred.

COPD exacerbation (Step 3 bundle):

Asthma: albuterol, ipratropium, systemic steroids, IV magnesium 2 g; rising CO₂ in asthma = imminent respiratory failure → intubate

Myasthenic crisis: IVIG or plasmapheresis, hold acetylcholinesterase inhibitors during crisis, treat triggers

Guillain-Barré: IVIG or plasmapheresis (steroids do NOT help); monitor FVC q4h

OHS: Nocturnal BiPAP, weight loss, treat OSA component with CPAP if no daytime hypercapnia

Board pearl: In COPD with pH <7.25 despite BiPAP, declining mental status, or hemodynamic instability → intubate. Don't delay.

Step 3 management: Schedule outpatient pulmonology follow-up within 1–4 weeks post-COPD exacerbation; reassess inhaler technique, vaccination status (influenza, PCV20, RSV, COVID), and smoking cessation.

Pharmacotherapy and Targeted Therapy — Respiratory Alkalosis

— Reassurance, slow controlled breathing coaching

— Avoid paper bag rebreathing — risk of hypoxia, no longer recommended

— Short-term benzodiazepine only if severe and other causes excluded; SSRI for chronic panic disorder

— Anticoagulation: LMWH, fondaparinux, or DOAC (apixaban, rivaroxaban) for hemodynamically stable

— Systemic thrombolysis (alteplase) or catheter-directed therapy for massive PE with hemodynamic instability or RV strain

— IVC filter only if anticoagulation contraindicated

— Urinary alkalinization with sodium bicarbonate drip (target urine pH 7.5–8) — traps salicylate as ionized form

— Hemodialysis for level >100 mg/dL acute (>60 chronic), AMS, pulmonary edema, renal failure, or refractory acidemia

— Never intubate cavalierly — losing the patient's compensatory hyperventilation drops pH catastrophically; if intubation needed, set high minute ventilation

— Activated charcoal if presenting <1–2 h post-ingestion

Respiratory alkalosis is a symptom, not a disease — find and fix the driver

Anxiety/panic-induced hyperventilation:

Pulmonary embolism:

Salicylate toxicity:

Sepsis: early broad-spectrum antibiotics within 1 h, fluid resuscitation (30 mL/kg crystalloid for hypotension/lactate >4), vasopressors (norepinephrine first-line), source control

Iatrogenic from mechanical overventilation: decrease respiratory rate or tidal volume; permissive hypercapnia in ARDS is acceptable (pH >7.20)

Hepatic encephalopathy with hyperventilation: lactulose, rifaximin; treat precipitant (GI bleed, infection, electrolytes)

Pregnancy: chronic mild respiratory alkalosis is physiologic — no treatment needed

Altitude: acetazolamide for acute mountain sickness prophylaxis (induces metabolic acidosis to enhance ventilation acclimation)

Board pearl: Mixed respiratory alkalosis + anion-gap metabolic acidosis in an adult with tinnitus = salicylate toxicity until proven otherwise. Get a level, don't wait for it to draw to start bicarbonate drip.

Key distinction: Hyperventilation with hypoxemia → PE/pneumonia/CHF; without hypoxemia → anxiety, pain, salicylates, sepsis, CNS, liver failure.

Special Populations — Elderly and Renal/Hepatic Impairment

— Baseline ↓respiratory muscle strength, ↓chest wall compliance, blunted ventilatory response to hypercapnia/hypoxia

— Higher risk of opioid- and benzodiazepine-induced hypoventilation — use lowest effective doses, avoid long-acting agents (diazepam, methadone), apply Beers criteria

— Atypical presentation: hypercapnia may present as delirium rather than dyspnea

— Polypharmacy and sedating co-medications (gabapentin, antihistamines, muscle relaxants) compound risk

— Chronic kidney disease blunts renal compensation for respiratory acidosis — patients with CKD + COPD develop acidemia more readily

— Acetazolamide (sometimes used to offset metabolic alkalosis in COPD on diuretics) requires dose reduction in CKD; avoid if CrCl <10

— Salicylate elimination depends on urinary alkalinization — harder to achieve in CKD; lower threshold for dialysis

— Bicarbonate replacement (when truly indicated) must consider sodium load and volume status in CKD/HF

— Chronic respiratory alkalosis is a hallmark of cirrhosis (progesterone-like effects, ammonia, ↑cardiac output)

— Hepatopulmonary syndrome: hypoxemia + intrapulmonary shunting; only definitive treatment is liver transplantation

— Sedative metabolism impaired — avoid benzodiazepines except lorazepam, oxazepam, temazepam (LOT — glucuronidated, no CYP); use cautiously

— Opioid clearance reduced — start at 25–50% standard dose

Elderly considerations:

Renal impairment:

Hepatic impairment:

Step 3 management: In an elderly post-op patient with new somnolence, check VBG and review the MAR for cumulative opioid/benzodiazepine doses before ordering head CT — iatrogenic hypercapnia is far more common than acute stroke in this scenario.

Board pearl: Elderly + COPD + new sedative = high risk for CO₂ narcosis; document baseline ABG and consider scheduled BiPAP in chronic CO₂ retainers.

CCS pearl: Adjust the problem list to include "chronic hypercapnia" so cross-covering teams don't aggressively normalize PaCO₂ — overcorrection causes post-hypercapnic metabolic alkalosis and seizures.

Special Populations — Pregnancy, Pediatrics, and Other Subgroups

— Chronic respiratory alkalosis is physiologic — progesterone stimulates the medullary respiratory center

— Normal pregnancy ABG: pH 7.40–7.47, PaCO₂ 28–32 mmHg, HCO₃⁻ 18–21 mEq/L

— A "normal" PaCO₂ of 40 in a pregnant patient suggests impending respiratory failure

— Pregnant asthmatics decompensate faster; intubation thresholds are lower

— Suspect PE with new dyspnea — workup with CTPA (preferred) or V/Q (lower fetal breast dose), do not withhold imaging

— Higher baseline respiratory rates; norms shift by age

— Bronchiolitis (RSV) and asthma are top causes of pediatric respiratory acidosis

— Rising CO₂ in a tiring child = imminent arrest — bag-valve-mask and prepare to intubate

— Salicylate toxicity in children may present with primary metabolic acidosis (less hyperventilation response than adults)

— Congenital central hypoventilation syndrome (PHOX2B mutation) — chronic hypercapnia, nocturnal hypoventilation

— BMI ≥30 + daytime PaCO₂ ≥45 + no alternative explanation

— 90% have concurrent OSA

— Treatment: PAP therapy (CPAP if pure OSA, BiPAP if persistent hypercapnia), weight loss, bariatric surgery consideration

— Nocturnal NIPPV when FVC <50% predicted or symptomatic nocturnal hypoventilation

— Improves quality of life and survival

— Atelectasis, splinting, residual anesthetic, opioid PCA — top causes of post-op hypercapnia

— Incentive spirometry, ambulation, multimodal analgesia (acetaminophen, gabapentin, regional blocks) reduce opioid need

Pregnancy:

Pediatrics:

Obesity hypoventilation syndrome (OHS):

Neuromuscular disease (ALS, muscular dystrophy):

Post-operative patients:

Board pearl: A pregnant patient with PaCO₂ of 40 and pH 7.36 is acidotic for pregnancy — investigate for asthma exacerbation, sepsis, or PE.

Step 3 management: In OHS, initiate outpatient BiPAP titration with sleep medicine within 2–4 weeks of hospital discharge; without it, 18-month mortality is high.

Complications and Adverse Outcomes

— CNS: confusion → stupor → coma (CO₂ narcosis), seizures, cerebral edema (vasodilation), elevated ICP

— Cardiovascular: ↓contractility, arrhythmias (especially with hypoxemia), pulmonary vasoconstriction, catecholamine refractoriness, hypotension

— Hyperkalemia: H⁺/K⁺ exchange shifts K⁺ extracellularly (less pronounced than in metabolic acidosis)

— Cor pulmonale — RV hypertrophy and failure from pulmonary hypertension

— Secondary erythrocytosis (chronic hypoxemia drives EPO)

— Poor sleep architecture, daytime somnolence, motor vehicle accidents

— Right-sided heart failure → hepatic congestion, peripheral edema

— Cerebral vasoconstriction → syncope, confusion, seizures (used therapeutically in elevated ICP, but only briefly)

— Coronary vasoconstriction → angina, MI risk

— ↓ionized Ca²⁺ → tetany, carpopedal spasm, QT prolongation, arrhythmias

— Hypokalemia, hypophosphatemia from intracellular shifts

— Leftward shift of oxyhemoglobin curve → reduced tissue O₂ delivery

— Overcorrection of chronic hypercapnia → post-hypercapnic metabolic alkalosis → seizures, arrhythmias; correct slowly

— Excessive O₂ in chronic CO₂ retainers → worsening hypercapnia

— Salicylate-poisoned patient intubated without high minute ventilation → catastrophic pH drop, cardiac arrest

— Bicarbonate administration in pure respiratory acidosis → worsens CO₂ retention

— COPD with chronic hypercapnia → 5-year mortality ~50%

— Each hospitalization for COPD exacerbation increases mortality risk

Acute severe respiratory acidosis (pH <7.20):

Chronic respiratory acidosis complications:

Acute severe respiratory alkalosis (pH >7.55):

Iatrogenic complications:

Long-term mortality markers:

Board pearl: Carpopedal spasm + perioral tingling + ABG showing alkalosis is a clinical (not lab) emergency only — reassurance and breathing coaching reverse it; calcium replacement is not first-line.

Key distinction: Hyperkalemia is more pronounced in inorganic metabolic acidosis (DKA, RTA) than respiratory acidosis — H⁺ exchanges with K⁺ less effectively when the anion is permeable (lactate, ketones don't shift K).

When to Escalate Care — ICU, Consult, and Inpatient Triage

— pH <7.25 or persistent acidemia despite NIPPV

— RR >35 or <8, declining mental status, inability to protect airway

— Hemodynamic instability, new arrhythmia

— Failure of NIPPV trial after 1–2 h

— Need for intubation/mechanical ventilation

— Severe asthma with normalizing or rising PaCO₂ (ominous sign)

— Neuromuscular disease with FVC <15–20 mL/kg or NIF less negative than −20 to −30 cmH₂O

— COPD exacerbation with pH <7.35 and PaCO₂ >45

— Acute cardiogenic pulmonary edema

— OHS, OSA with acute hypercapnia

— Immunocompromised with hypoxemic respiratory failure

— Avoid in: impaired consciousness, vomiting/airway protection issues, facial trauma, hemodynamic instability, recent upper GI surgery

— Pulmonology/critical care for refractory hypercapnia, mechanical ventilation decisions

— Neurology for suspected neuromuscular cause

— Toxicology/poison control (1-800-222-1222) for overdose

— Nephrology for dialysis in severe salicylate toxicity

— Sleep medicine for OSA/OHS outpatient management

— Anesthesia for difficult airway anticipated

— Floor: chronic stable hypercapnia, mild alkalosis from anxiety/early sepsis

— Step-down/telemetry: COPD exacerbation on NIPPV, stable PE on anticoagulation

— ICU: intubated, hemodynamically unstable, severe acid-base derangement, salicylate level >100, massive PE

Indications for ICU admission in respiratory acidosis:

Indications for NIPPV (BiPAP) trial:

Consults:

Floor vs step-down vs ICU triage:

CCS pearl: In CCS cases, order ABG, place on monitor, give O₂ to target SpO₂ 88–92%, start nebulizers and steroids, initiate BiPAP — then move clock forward 1–2 h and recheck ABG. Acting in parallel saves virtual minutes and demonstrates competency.

Board pearl: A "normalizing" PaCO₂ in a fatigued asthmatic with persistent severe distress is a pre-arrest finding — call anesthesia, prepare ketamine and rocuronium, intubate.

Key Differentials — Same-Category Causes (Other Respiratory Acid-Base Etiologies)

— CNS depression: opioids, benzodiazepines, barbiturates, alcohol, anesthetics, brainstem stroke, encephalitis, elevated ICP, Ondine's curse (central hypoventilation)

— Neuromuscular: Guillain-Barré, myasthenia gravis, ALS, botulism, organophosphate poisoning, hypokalemic/hypophosphatemic weakness, critical illness myopathy, muscular dystrophy, polio, tick paralysis, high cervical spine injury

— Chest wall/pleural: kyphoscoliosis, ankylosing spondylitis, massive obesity (OHS), flail chest, large pleural effusion, tension pneumothorax, circumferential burn eschar

— Upper airway obstruction: foreign body, angioedema, anaphylaxis, epiglottitis, laryngospasm, vocal cord dysfunction, OSA

— Lower airway/parenchymal: severe COPD, status asthmaticus, ARDS (late), severe pneumonia, pulmonary edema (advanced), pulmonary fibrosis (end-stage), bronchiectasis

— CNS-driven: anxiety, pain, fever, CVA, meningitis, encephalitis, tumor, hepatic encephalopathy, head trauma

— Hypoxemia-driven: high altitude, PE, pneumonia, CHF, asthma (early), pneumothorax, ILD, anemia (severe), right-to-left shunt

— Pulmonary-receptor stimulation: PE, pneumonia, pulmonary edema, ILD

— Drug-induced: salicylates, progesterone, catecholamines, nicotine, methylxanthines, doxapram

— Hormonal/metabolic: pregnancy, hyperthyroidism, hepatic failure

— Iatrogenic: mechanical overventilation

— Sepsis (early) — multifactorial

Respiratory acidosis differential by mechanism:

Respiratory alkalosis differential by mechanism:

Board pearl: Sepsis can cause both respiratory alkalosis (early, from cytokine-driven hyperventilation) and metabolic acidosis (lactic, late) — a mixed disorder evolution.

Key distinction: OSA alone causes nocturnal respiratory acidosis with normal daytime gases; OHS (Pickwickian) has daytime hypercapnia. Both can coexist; PFTs and overnight oximetry distinguish.

Step 3 management: A patient with chronic hypercapnia of unclear etiology needs PFTs + MIP/MEP + sleep study + neuro exam before assigning a primary diagnosis.

Key Differentials — Other-Category (Mixed Disorders)

— Respiratory alkalosis + AGMA: salicylate toxicity, sepsis with lactic acidosis, advanced liver failure with hyperventilation

— Respiratory acidosis + metabolic acidosis: cardiac arrest, severe pulmonary edema with shock, COPD + sepsis, intoxication with both CNS depressant and methanol/ethylene glycol

— Respiratory acidosis + metabolic alkalosis: COPD on loop diuretics, COPD with vomiting, chronic CO₂ retainer with NG suction

— Respiratory alkalosis + metabolic alkalosis: cirrhosis with diuretics or vomiting, pregnancy with hyperemesis, ventilated patient with NG suction

— Triple disorder: salicylate poisoning with vomiting (resp alkalosis + AGMA + metabolic alkalosis); decompensated COPD with sepsis and vomiting

— ΔAG = AG − 12; ΔHCO₃ = 24 − HCO₃

— ΔAG/ΔHCO₃ <1: AGMA + concurrent NAGMA (e.g., DKA with resolving ketosis getting NS → hyperchloremic acidosis)

— ΔAG/ΔHCO₃ ≈ 1–2: pure AGMA

— ΔAG/ΔHCO₃ >2: AGMA + concurrent metabolic alkalosis (HCO₃ "preserved" higher than expected)

— Looks "normal" by pH but AG is wide → mixed primary respiratory alkalosis + AGMA → salicylate toxicity

Mixed disorders are the Step 3 sweet spot. Recognize them by checking compensation against expected formulas.

Common mixed patterns:

Anion gap and delta-delta in mixed disorder detection:

Always check anion gap even when ABG suggests pure respiratory disorder — sneaky AGMA hides behind respiratory compensation

Worked example: pH 7.40, PaCO₂ 25, HCO₃ 15, Na 140, Cl 100, AG = 25

Board pearl: A "normal pH" never rules out an acid-base disorder. Always calculate the anion gap and check expected compensation.

Key distinction: Use Winters formula (expected PaCO₂ = 1.5×HCO₃ + 8 ± 2) when the primary is metabolic acidosis; deviations reveal coexisting respiratory disorders.

Step 3 management: When you spot a triple acid-base disorder, systematically address each component — e.g., in salicylate-poisoned vomiting patient: bicarbonate drip, IV fluids with potassium repletion, antiemetics, and dialysis criteria assessment.

Secondary Prevention, Discharge Medications, and Long-Term Plan

— Inhaled regimen optimization per GOLD: LAMA + LABA ± ICS (ICS if eosinophils ≥300 or ≥2 exacerbations/year)

— Smoking cessation — varenicline, bupropion, NRT; brief counseling at every visit

— Vaccinations: annual influenza, PCV20 once, RSV (≥60 y), Tdap, COVID booster, zoster (≥50 y)

— Pulmonary rehabilitation referral — proven mortality and readmission benefit

— Action plan with rescue inhaler and steroid/antibiotic prescription for early exacerbation treatment

— Assess for long-term oxygen therapy: resting SpO₂ ≤88% or PaO₂ ≤55 mmHg (or ≤59 with cor pulmonale/polycythemia)

— DOAC for ≥3 months (provoked) or indefinite (unprovoked, recurrent, persistent risk factor)

— Thrombophilia workup only if changes management (consider after acute phase)

— Compression stockings no longer routinely recommended

— PAP adherence is the single most important predictor of outcome — review usage data at each visit

— Weight loss (5–10% improves AHI; bariatric surgery for refractory)

— Avoid alcohol and sedatives at bedtime

— Driving safety counseling — assess for excessive daytime sleepiness

— Nocturnal NIPPV when criteria met (FVC <50%, nocturnal symptoms, daytime hypercapnia)

— Multidisciplinary clinic (neurology, pulmonology, PT/OT, speech, nutrition, palliative care)

— Advance care planning early — discuss tracheostomy, long-term ventilation preferences

— SSRI/SNRI first-line, CBT, breathing retraining

— Avoid chronic benzodiazepines

Post-COPD exacerbation discharge bundle:

Post-PE management:

OSA/OHS:

Neuromuscular disease:

Anxiety/panic disorder with hyperventilation:

Board pearl: Long-term oxygen therapy in qualifying COPD patients is the only pharmacologic intervention proven to reduce mortality along with smoking cessation.

Step 3 management: Document goals of care in advanced COPD with chronic hypercapnia and frequent exacerbations — palliative care consult is appropriate and reduces readmissions.

Follow-Up, Monitoring Parameters, and Rehab/Counseling

— COPD exacerbation: PCP visit within 1–2 weeks, pulmonology within 4 weeks, repeat spirometry at 6–8 weeks (post-exacerbation values misleading earlier)

— PE: anticoagulation clinic or PCP at 1 week, hematology if thrombophilia evaluation needed, reassess anticoagulation duration at 3 and 6 months

— OHS on new BiPAP: sleep medicine at 1 month for compliance data, then q3–6 months

— Salicylate toxicity: psychiatry follow-up if intentional ingestion, repeat metabolic panel at 1 week

— Home pulse oximetry for selected patients (LTOT, OHS)

— Spirometry annually for COPD (FEV₁ decline, GOLD staging updates)

— Sleep study repeat if weight changes >10% or symptoms recur

— CBC for polycythemia in chronic hypoxemia

— BNP and echocardiogram for cor pulmonale surveillance

— INR if on warfarin (rare for PE now); no monitoring needed for DOACs but check renal function annually

— 6–8 weeks, 2–3 sessions/week

— Exercise training, breathing techniques, nutrition, education, psychosocial support

— Indicated for COPD GOLD B–E, post-exacerbation, ILD, pre-lung transplant

— Improves dyspnea, exercise tolerance, QoL, reduces readmissions

— Smoking cessation at every visit (5 A's: Ask, Advise, Assess, Assist, Arrange)

— Inhaler technique demonstration — most patients use them incorrectly

— Recognize warning signs: increased dyspnea, sputum change, edema, confusion

— Medication reconciliation — flag opioid/benzodiazepine prescriptions that risk hypoventilation

— Vaccination updates

Post-discharge follow-up cadence:

Monitoring parameters:

Pulmonary rehabilitation:

Counseling priorities:

Board pearl: 30-day readmission for COPD is a CMS quality metric — early follow-up (within 7–14 days) reduces it; this is high-yield for Step 3 systems-based practice questions.

Step 3 management: When a patient with chronic hypercapnia is admitted, avoid scheduled opioids and benzodiazepines post-discharge — coordinate with primary team to taper and use multimodal analgesia.

Ethical, Legal, and Patient Safety Considerations

— Patient with CO₂ narcosis lacks capacity — proceed under emergency exception or with surrogate decision-maker; document carefully

— DNR/DNI status: clarify before intubation; "do not intubate" does not preclude NIPPV unless patient specifies "no PAP." Have this conversation early in COPD/ALS clinic, not during crisis

— Patients with advanced ALS may decline tracheostomy ventilation despite imminent respiratory failure — respect autonomy, transition to comfort care with NIPPV ± opioids for dyspnea

— Discharge of chronic CO₂ retainers on home O₂ requires explicit instructions to maintain SpO₂ 88–92%, not higher — written and verbal

— Medication reconciliation: re-prescribing pre-admission sedatives in a patient who decompensated from them is a sentinel event

— Communicate baseline ABG/PaCO₂ to PCP — prevents inappropriate "normalization" by other providers

— Suspected intentional salicylate ingestion → psychiatric evaluation before discharge; assess for further intent, safety plan, lethal means restriction

— Driving safety in OSA/OHS with excessive daytime sleepiness: many states require physician reporting (varies); always document counseling against driving while symptomatic

— Opioid overdose: offer naloxone prescription to patient and household, opioid use disorder treatment (buprenorphine), harm reduction resources

— Continuous capnography for patients on PCA opioids in high-risk groups

— Never prescribe benzodiazepines and opioids together in opioid-naive elderly/COPD patients — black box warning

— Bedside spirometry q4h in neuromuscular crisis is a safety standard — missed trends precede arrest

— Smoking cessation resources and pulmonary rehab access vary by insurance; advocate and document barriers

Informed consent edge cases:

Transition-of-care risks:

Mandatory reporting and safety:

Patient safety in inpatient setting:

Health equity:

Board pearl: A patient with severe COPD repeatedly admitted with hypercapnic failure who has not had a goals-of-care discussion represents a system failure — initiate palliative care consult on this admission.

Step 3 management: Always co-prescribe naloxone when continuing opioids in a patient who survived an opioid-related respiratory acidosis event.

High-Yield Associations and Rapid-Fire Clinical Facts

Acute respiratory acidosis: HCO₃ ↑ 1 per 10 ↑PaCO₂; pH ↓ 0.08 per 10 ↑PaCO₂

Chronic respiratory acidosis: HCO₃ ↑ 3.5–4 per 10 ↑PaCO₂; pH ↓ 0.03 per 10 ↑PaCO₂

Acute respiratory alkalosis: HCO₃ ↓ 2 per 10 ↓PaCO₂

Chronic respiratory alkalosis: HCO₃ ↓ 4–5 per 10 ↓PaCO₂

Winters formula: expected PaCO₂ = 1.5(HCO₃) + 8 ± 2

Metabolic alkalosis compensation: PaCO₂ ↑ 0.7 per 1 ↑HCO₃ (rarely >55)

Salicylate toxicity = primary respiratory alkalosis + AGMA + tinnitus + hyperthermia

Asthma with normalizing CO₂ = pre-arrest

COPD + loop diuretic = mixed respiratory acidosis + metabolic alkalosis

Pregnancy = chronic respiratory alkalosis (PaCO₂ 28–32 is normal)

OHS = daytime PaCO₂ ≥45 + BMI ≥30, no other cause

Cor pulmonale = chronic hypoxemia/hypercapnia → pulmonary HTN → RV failure

CO₂ narcosis at PaCO₂ ~70–80 acute; chronic retainers tolerate much higher

A-a gradient normal + hypercapnia → think CNS/neuromuscular cause

GBS workup: FVC q4h, NIF, intubate at FVC <20 mL/kg

PE labs: elevated D-dimer, hypoxemia with A-a gap, may have normal CXR; CTPA confirmatory

Hepatopulmonary syndrome: triad of liver disease + hypoxemia + intrapulmonary shunting; orthodeoxia

Acetazolamide for altitude sickness, post-hypercapnic met alkalosis

Carpopedal spasm in hyperventilation from ↓ionized Ca²⁺ (alkalemia shifts to bound form)

Naloxone dosing: titrate to respirations, not consciousness; expect re-sedation

NIPPV reduces mortality and intubation in COPD exacerbation with pH <7.35

LTOT criteria in COPD: PaO₂ ≤55 or SpO₂ ≤88%; ≤59/≤89 if cor pulmonale or HCT >55%

Target SpO₂ in chronic CO₂ retainers: 88–92%, not higher

Permissive hypercapnia in ARDS: pH ≥7.20 acceptable, low TV (6 mL/kg IBW) priority

Board pearl: "Anion gap is the salicylate question" — calculate AG on every ABG with respiratory alkalosis.

Key distinction: Acute vs chronic respiratory disorders are distinguished by magnitude of HCO₃ compensation, not by clinical timing alone — the kidney "tells you" how long the disorder has existed.

Board Question Stem Patterns

Stem 1 (Salicylate toxicity): A 22-year-old presents with tinnitus, tachypnea, vomiting, and confusion. ABG: pH 7.40, PaCO₂ 22, HCO₃ 14; AG = 22. → Mixed primary respiratory alkalosis and AGMA → salicylate toxicity. Next step: salicylate level + sodium bicarbonate drip; dialysis if level >100 or AMS.

Stem 2 (COPD on diuretic): 68-year-old with COPD on furosemide, ABG pH 7.46, PaCO₂ 60, HCO₃ 42. → Mixed chronic respiratory acidosis + metabolic alkalosis. Hold or reduce diuretic; consider acetazolamide.

Stem 3 (Asthma fatigue): 17-year-old with severe asthma, RR now 14 (was 32), "calmer." ABG: pH 7.32, PaCO₂ 48, HCO₃ 24. → Impending respiratory failure — intubate immediately, do not be reassured by "improvement."

Stem 4 (Opioid overdose): Unresponsive patient, pinpoint pupils, RR 6. ABG: pH 7.18, PaCO₂ 70, HCO₃ 25. → Acute respiratory acidosis with appropriate compensation; give naloxone, BVM ventilation, observation.

Stem 5 (PE): Postpartum patient with sudden dyspnea, SpO₂ 89%. ABG: pH 7.50, PaCO₂ 26, HCO₃ 20. → Acute respiratory alkalosis with hypoxemia → CTPA, anticoagulation.

Stem 6 (CO₂ narcosis from O₂): COPD patient given 6 L NC, becomes obtunded. ABG: pH 7.21, PaCO₂ 95, HCO₃ 36. → Acute on chronic respiratory acidosis from over-oxygenation; reduce FiO₂ to target SpO₂ 88–92%, NIPPV.

Stem 7 (Pregnancy norms): Pregnant woman with mild dyspnea, ABG pH 7.44, PaCO₂ 30, HCO₃ 20. → Normal pregnancy — no intervention.

Stem 8 (OHS): BMI 45 patient with daytime somnolence, morning headaches. ABG pH 7.36, PaCO₂ 55, HCO₃ 32. → Chronic respiratory acidosis from OHS → sleep study + nocturnal BiPAP.

Stem 9 (Anxiety): 24-year-old with chest tightness, perioral tingling, normal CXR/EKG/troponin. → Acute respiratory alkalosis from panic — reassurance, breathing coaching, SSRI for chronic.

Stem 10 (Salicylate + intubation pitfall): Patient with salicylate toxicity intubated with low minute ventilation — pH plummets, arrest. → Match or exceed the patient's pre-intubation minute ventilation.

Board pearl: Look for the inconsistency between pH and PaCO₂ direction — that's where mixed disorders hide and points are won.

Step 3 management: Always state your compensation calculation, the disorder name, and the next clinical action — that triad is the answer Step 3 wants.

One-Line Recap

The Step 3 essence: identify the primary respiratory acid-base disorder, classify it as acute or chronic by the magnitude of renal HCO₃⁻ compensation, calculate expected compensation to expose mixed disorders, and treat the underlying cause rather than the number.

Compensation cheat sheet: Acute resp acidosis → ΔHCO₃ = 1 per 10 ΔPaCO₂; chronic → 3.5–4 per 10. Acute resp alkalosis → ΔHCO₃ = 2 per 10; chronic → 4–5 per 10. Winters for met acidosis: PaCO₂ = 1.5(HCO₃) + 8 ± 2.

Mixed-disorder triggers to memorize: salicylate toxicity (resp alkalosis + AGMA), COPD on diuretics (resp acidosis + met alkalosis), cardiac arrest (resp + met acidosis), cirrhosis + vomiting (resp + met alkalosis), and pregnancy norms (chronic resp alkalosis baseline).

Management cornerstones: target SpO₂ 88–92% in chronic CO₂ retainers, BiPAP for COPD with pH <7.35, naloxone for opioid overdose, bicarbonate drip ± dialysis for salicylates, intubate the tiring asthmatic with normalizing CO₂, and never give bicarbonate for pure respiratory acidosis.

Step 3 systems thinking: schedule pulmonology follow-up within 1–4 weeks post-exacerbation, prescribe naloxone with opioids, vaccinate (flu, PCV20, RSV, COVID), refer to pulmonary rehab, initiate goals-of-care discussions in advanced disease, and audit medication lists for sedatives that drove the decompensation.

Highest-yield trap: a "normal" pH never excludes acid-base pathology — always calculate the anion gap and verify compensation matches the expected formula before signing off the ABG.